StockData
Starling Oncology, Inc. logo

Starling Oncology, Inc. (STLN) income statement

STLNNasdaqServices-Offices & Clinics of Doctors of MedicineFiscal year ends December 31Also trades as DFPH, STLNW
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 6, 2026Score 7/30
$3.00−0.18 (-5.66%)

Close on Nov 20, 2026Market cap $305.75MP/E –Yield –

See a number that looks wrong?